Pharmaceuticals News
-
Egypt's exports of medical, cosmetics grew by 45% in 2022
The African market is promising for the sector's products during 2023, but some obstacles must be dealt with.
-
Egypt’s VACSERA in talks with China’s SINOVAC over vaccines plant construction
In June 2022, VACSERA settled debts of EGP 712.5 million for National Investment Bank, the report showed.
-
Hikma, Celltrion Healthcare sign up for anti-cancer drug
Celltrion Healthcare will handle the development, manufacturing and supply of Vegzelma and Hikma will handle the commercialization.
-
Egyptian Health Minister discusses bilateral cooperation with MSD Pharmaceutical Company
The minister discussed cooperation with the MSD company to provide the latest oncological treatments (immunotherapy) for breast cancer patients.
-
Egypt records 46.3% higher medical, pharmaceutical exports
Moreover, exports of medical industries rose by 11.30% YoY during January-August 2022 to reach $69 million from $62 million.
-
Egypt to produce cancer drugs within 6 months: official
Producing medicines locally would reduce the import bill, absorb pharmacy and science graduates, and provide medicine on time.
-
Eli Lilly partners with generics maker Eva to boost insulin access in Africa
Under the partnership, the distribution of insulin to middle- and low-income countries—most of them in Africa—is expected to begin in 18 months.
-
Egypt to produce cancer treatments locally in partnership with foreign companies
Egypt has no shortage in medicinal drugs and that local companies fulfill 90 percent of needs.
-
Alex Pharma’s profits increase by 18.1% YoY in 4 months
The company’s operating revenues rose to EGP 464.415 million in the July-October period of FY 2022/2023.
-
GSK Egypt’s consolidated profit skyrockets 1,213% YoY in 9 months
Revenues soared to EGP 1.163 billion in nine months to September 30th from EGP 630.477 million the year before.
-
Pfizer announces its future strategy in the Egyptian market
Pfizer announced its success in providing the latest treatments to 7 million patients in Egypt, and its goal to reach 7.6 million end of year.
-
Bioventure, Minapharm and MiGenTra sign an exclusive agreement
The agreement is for the commercialization of multiple biosimilar candidates developed and manufactured by Alvotech.
-
Biontech must fight
Biontech delivered a vaccine against Corona at a record pace. In the meantime, demand for Comirnaty, still the world's top-selling drug, is flagging.
-
Egypt is pioneer in pharma industry localisation in MENA
El-Dababi made his comments during his participation in the third edition of Al-Ahram Establishment’s two-day pharmaceutical conference.
-
Project: Medicine (14 contracts)
Cairo: Supply of different types of medicine under fourteen contracts
-
Egypt Plans to Make 1 Billion Sinovac Vaccines a Year
Under the deal with the Chinese pharmaceutical company, a factory in Cairo will produce more than 200 million doses per year to cover "national needs"
-
IFC partners with Rameda to ‘green’ its pharmaceutical business
“greening" operations means improving production efficiencies and boosting the company’s productivity.
-
Egypt Outpacing Middle East and Africa’s Top Markets
Four years after Egypt enacted a new universal health law, the country’s pharmaceutical market has consolidated itself as the fastest growing in MENA.
-
Africa Health ExCon to help Egypt become pharmaceutical hub
The organisation of the Africa Health ExCon (AHE) in Egypt is a golden opportunity for the country to become a hub for exporting pharmaceuticals.
-
Egypt to provide two new coronavirus drugs on market soon
One of the drugs, Merck, is taken orally, and four Egyptian companies have applied to manufacture it locally.